Lantus and Amicar drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Amicar (aminocaproic acid). Common drug interactions include fatigue among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Lantus and Amicar. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Lantus?
Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.
What is Amicar?
Amicar has active ingredients of aminocaproic acid. eHealthMe is studying from 1,323 Amicar users. Check the latest studies of Amicar.
29 people who take Lantus and Amicar together, and have interactions are studied.

What are the common drug interactions of Lantus and Amicar, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
- Myelofibrosis (a disease in which abnormal blood cells and fibres build up inside the bone marrow)
- Pain
- Therapeutic response decreased (less preventive response)
- Headache (pain in head)
- Gastroenteritis (inflammation of stomach and intestine)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Febrile neutropenia (fever with reduced white blood cells)
male:
- Pain
- Renal failure (kidney dysfunction)
- Emotional distress
- Pain in extremity
- Pyrexia (fever)
- Acute respiratory failure
- Anaemia (lack of blood)
- Asthenia (weakness)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Cardiomegaly (increased size of heart than normal)
What are the common drug interactions of Lantus and Amicar, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Vomiting
- Weight increased
- Wheezing (a high-pitched whistling sound made while you breath)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Panic attack
- Weight fluctuation
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Abdominal distension
- Arthralgia (joint pain)
40-49:
- Chronic kidney disease
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Infection
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
50-59:
- Pain
- Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
- Renal failure acute (rapid kidney dysfunction)
- Renal failure (kidney dysfunction)
- Anxiety
- Death
- Fear
- Multi-organ failure (multisystem organ failure)
- Renal injury (kidney injury)
- Acute respiratory failure
60+:
- Anxiety
- Emotional distress
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Death
- Fungaemia (fungi circulate in the blood)
- Renal impairment (severely reduced kidney function)
- Stress
- Fear
- Injury
- Multi-organ failure (multisystem organ failure)
What are the existing conditions these people have? *
- Nausea (feeling of having an urge to vomit): 6 people, 20.69%
- Respiratory Disorder (respiratory disease): 5 people, 17.24%
- Cystic Fibrosis (disease of the secretary glands): 5 people, 17.24%
- Anaesthesia: 5 people, 17.24%
- Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 13.79%
- Decreased Ventricular Afterload (decreased tension or stress developed in the wall of the left ventricle during ejection): 4 people, 13.79%
- Pain In Extremity: 3 people, 10.34%
- Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Lantus and Amicar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lantus and Amicar:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lantus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Amicar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lantus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Amicar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin glargine recombinant and aminocaproic acid (the active ingredients of Lantus and Amicar, respectively), and Lantus and Amicar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Versed cause Taste - Impaired? - a second ago
- Drug interactions of Firdapse and Vesicare - 5 seconds ago
- Osteoarthritis and Irritability - 11 seconds ago
- Could Adempas cause Salivary Hypersecretion? - 23 seconds ago
- Could Docetaxel cause Atrial Fibrillation/Flutter? - 24 seconds ago
- Could Prednisone cause Bezoar? - 24 seconds ago
- Could Mupirocin cause Pollakiuria? - 26 seconds ago
- Could Theo-24 cause Insomnia? - 28 seconds ago
- Could Ciprofloxacin cause Synovitis? - 31 seconds ago
- Could Lasix cause Limb Crushing Injury? - 33 seconds ago